2017
DOI: 10.1016/j.jff.2017.09.034
|View full text |Cite
|
Sign up to set email alerts
|

Probiotic characterization of Enterococcus faecium por1: Cloning, over expression of Enterocin-A and evaluation of antibacterial, anti-cancer properties

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
17
0
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 47 publications
(18 citation statements)
references
References 47 publications
0
17
0
1
Order By: Relevance
“…Enterocin-A Effective antibacterial and anti-biofilm activity against food born as well as human bacterial pathogens (Ankaiah, Esakkiraj, Perumal, Ayyanna, & Venkatesan, 2017).…”
Section: Enterococcus Faeciummentioning
confidence: 99%
“…Enterocin-A Effective antibacterial and anti-biofilm activity against food born as well as human bacterial pathogens (Ankaiah, Esakkiraj, Perumal, Ayyanna, & Venkatesan, 2017).…”
Section: Enterococcus Faeciummentioning
confidence: 99%
“…Enterocin 12a inhibited the proliferation of all the tested cancer cell lines in a dose-dependent manner. Another enterocin i.e., enterocin A was earlier shown to reduce the viabilities of human cancer cell lines viz., HeLa, HT-29, AGS, and Caco-2 selectively by 60% at the maximum dose of 120 μg/ml [41]. However, as compared to enterocin-A, 12a appeared to be more potent as it reduced the viabilities of all the tested cell lines in the range 64-90% at a maximum dose of 5 μg/ml.…”
Section: Discussionmentioning
confidence: 90%
“…23 Ankaiah et.al studied the anti-cancer activity of enterocin-A against human colon, gastric (HT-29, Caco-2 and AGS) and cervical (HeLa) cancer cell lines and they found out that ent-A was able to induce apoptosis in HeLa cell line at a concentration of 120μg/ml, so that 53.93% of the cells had delayed apoptosis and 5.8% showed a primary apoptosis. 24 Fathizadeh et al in a review study investigated the role of bacteriocins as new potential therapeutic candidates in cancer therapy. They nd out that Evidence suggests that bacteriocins such as colcins, nisins, pediocins, pyocins, and bovocins are able to inhibit tumor growth at various stages by activating or inhibiting various cellular and molecular signaling pathways.…”
Section: Discussionmentioning
confidence: 99%